ArticleInternational journal of hematology2014

Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia.

Limin Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.